SITC 2023: The Spatially-resolved Proteomic Atlas of the Tumor Immune Architecture of HER2-positive Breast Cancer and Response to Neoadjuvant Anti-HER2 Therapy-based Chemotherapy
Please complete this form to access the requested resource.
Please complete this form to access the requested resource.